Does TREPROSTINIL Cause Product container issue? 37 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Product container issue have been filed in association with TREPROSTINIL (TYVASO). This represents 0.0% of all adverse event reports for TREPROSTINIL.
37
Reports of Product container issue with TREPROSTINIL
0.0%
of all TREPROSTINIL reports
3
Deaths
15
Hospitalizations
How Dangerous Is Product container issue From TREPROSTINIL?
Of the 37 reports, 3 (8.1%) resulted in death, 15 (40.5%) required hospitalization.
Is Product container issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 37 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Product container issue?
CYCLOSPORINE (910)
MINOXIDIL (556)
MOMETASONE FUROATE (450)
FORMOTEROL\MOMETASONE FUROATE (375)
LIFITEGRAST (244)
ALBUTEROL (192)
LATANOPROST (158)
CARBOXYMETHYLCELLULOSE\GLYCERIN (123)
BRIMONIDINE (121)
ACETAMINOPHEN (118)
Which TREPROSTINIL Alternatives Have Lower Product container issue Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE